Our clients include over 90 companies listed in Switzerland, around half of which are SMI and SMIM companies across all industries. In addition, 35% of IPOs conducted on the SIX Swiss Exchange since 2017 have involved HCM (including listings such as Molecular Partners, Medacta, Landis+Gyr, SIG, etc.).
Listed companies are obliged to act in the interests of their shareholders, often with the aim of increasing company value and dividends. Large institutional investors or proxy advisors can influence the strategy and management of the company. In addition to shareholders, companies should consider the interests of other stakeholders such as employees, customers, suppliers and the public.
We align our service with a stakeholder engagement process in order to optimally meet the high demands of listed companies in terms of transparency and regulation as well as the increased influence of institutional investors and proxy advisors.